{"schemaVersion":"wpf-profile-export-v1","exportedAt":"2026-09-18T15:17:28.808Z","profile":{"slug":"semax","name":"Semax","aliases":[],"category":"Synthetic regulatory peptide"},"synthesis":{"mechanism":"Synthetic ACTH-fragment-derived heptapeptide studied chiefly in Russian-language neurobiology and clinical literature.","evidence":"Source identities are PubMed-resolved and provisionally graded by study design. Full-text findings, bias, applicability, contradictions, and regulatory interpretation remain pending.","safety":"Authorization is jurisdiction-specific; FDA identifies limited safety information and potential compounding risks.","observationalBoundary":"A minimum 25-source PubMed corpus and chemistry record are staged for accountable review. This profile remains suppressed until authorized scientific and publication approval.","openQuestions":"Which findings survive full-text risk-of-bias review? Which populations, formulations, routes, doses, comparators, durations, and endpoints are directly supported? What jurisdiction-specific authorization applies?"},"completion":{"version":"wpf-profile-v1.0","complete":false,"checks":[{"key":"overview","passed":true,"actual":118,"required":100,"severity":"blocking"},{"key":"evidence_summary","passed":true,"actual":182,"required":100,"severity":"blocking"},{"key":"safety_summary","passed":true,"actual":114,"required":100,"severity":"blocking"},{"key":"archive_boundary","passed":true,"actual":175,"required":75,"severity":"blocking"},{"key":"open_questions","passed":true,"actual":213,"required":75,"severity":"blocking"},{"key":"verified_sources","passed":true,"actual":25,"required":25,"severity":"blocking"},{"key":"reviewed_sources","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"chemistry","passed":true,"actual":true,"required":true,"severity":"blocking"},{"key":"regulatory_context","passed":true,"actual":2,"required":2,"severity":"blocking"},{"key":"claims","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"claim_traceability","passed":true,"actual":0,"required":0,"severity":"blocking"},{"key":"regulatory_freshness","passed":true,"actual":0,"required":0,"severity":"warning"}],"failures":["reviewed_sources","claims"]},"chemistry":{"id":"b09b48f8f9cca90be9480c99b5f02fee","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","molecularFormula":"C37H51N9O10S","molecularWeight":813.9,"aminoAcidSequence":"MEHFPGP","smiles":null,"inchi":null,"inchikey":"AFEHBIGDWIGTEH-AQRCPPRCSA-N","structureImageUrl":null,"createdAt":"2026-09-09T11:44:22.278Z","updatedAt":"2026-09-09T11:44:22.278Z"},"evidence":[{"id":"07626ecc-78cb-5384-9811-e4f1760f2a8d","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41490200/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining therapeutic peptides in orthopaedics: applications, challenges, and future directions. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Omar F Rahman; Steven J Lee; William A Seeds","publishingOrg":"Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews","publicationYear":2026,"doi":"10.4155/fdd-2022-0009","pubmedId":"41490200","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.4155/fdd-2022-0009","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.4155/fdd-2022-0009","pmid":"41490200","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"6a5c195d-7228-55d8-a9fd-cb78fe3043ba","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/42021992/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining therapeutic peptides in gerontology: mechanisms and applications for healthy aging. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Volodymyr Mavrych; Inna Shypilova; Olena Bolgova","publishingOrg":"Frontiers in aging","publicationYear":2026,"doi":"10.1038/s41392-022-00904-4","pubmedId":"42021992","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1038/s41392-022-00904-4","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1038/s41392-022-00904-4","pmid":"42021992","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"596dab1d-631d-511c-89ef-3819b3baebdd","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40650034/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining genes that associated with action of acth-like peptides with neuroprotective potential in rat brain regions with different degrees of ischemic damage. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ivan B Filippenkov; Yana Yu Shpetko; Daria A Ales; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Natalia K Fomina; Leonid V Gubsky; Lyudmila A Andreeva; Nikolay F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova","publishingOrg":"International journal of molecular sciences","publicationYear":2025,"doi":"10.1101/gr.1239303","pubmedId":"40650034","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1101/gr.1239303","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1101/gr.1239303","pmid":"40650034","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"19fbe397-b63f-5152-938b-f18990cece78","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40692165/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining semax peptide targets the μ opioid receptor gene oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Rongjie Liu; Yituo Chen; Haosheng Huang; Xiang Li; Junlei Lv; Liting Jiang; Hongyi Jiang; Chenyu Wu; Weikai Chen; Hongwei Xu; Zhefan Zhu; Haoxu Cai","publishingOrg":"British journal of pharmacology","publicationYear":2025,"doi":"10.1111/bph.70122","pubmedId":"40692165","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1111/bph.70122","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1111/bph.70122","pmid":"40692165","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"3aba74a5-7e5c-577e-8f0d-8c6d513aadf4","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41479572/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining the potential of the peptide drug semax and its derivative for correcting pathological impairments in the animal model of alzheimer's disease. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"A I Radchenko; E V Kuzubova; A A Apostol; V A Mitkevich; L A Andreeva; S A Limborska; Yu V Stepenko; V S Shmigerova; A V Solin; M V Korokin; M V Pokrovskii; N F Myasoedov","publishingOrg":"Acta naturae","publicationYear":2025,"doi":"10.32607/actanaturae.27808","pubmedId":"41479572","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.32607/actanaturae.27808","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.32607/actanaturae.27808","pmid":"41479572","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"ad23b59d-47f3-5ee4-b57a-25e119f98b5d","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39767736/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining acth-like peptides compensate rat brain gene expression profile disrupted by ischemia a day after experimental stroke. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ivan B Filippenkov; Yana Yu Shpetko; Vasily V Stavchansky; Alina E Denisova; Leonid V Gubsky; Lyudmila A Andreeva; Nikolay F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova","publishingOrg":"Biomedicines","publicationYear":2024,"doi":"10.1038/s41598-022-20623-8","pubmedId":"39767736","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1038/s41598-022-20623-8","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1038/s41598-022-20623-8","pmid":"39767736","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"d82f8a1c-86cf-5bd7-95f0-4a545b597d24","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/34201112/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining brain protein expression profile confirms the protective effect of the acth(4-7)pgp peptide (semax) in a rat model of cerebral ischemia-reperfusion. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Olga Yu Sudarkina; Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Liya V Valieva; Julia A Remizova; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska","publishingOrg":"International journal of molecular sciences","publicationYear":2021,"doi":"10.32388/uq8dyz","pubmedId":"34201112","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.32388/uq8dyz","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.32388/uq8dyz","pmid":"34201112","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"30314958-dfed-57dc-bcd9-11241460b3a0","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/33418449/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining semax, synthetic acth(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Nataliya Yu Glazova; Daria M Manchenko; Maria A Volodina; Svetlana A Merchieva; Ludmila A Andreeva; Vladimir S Kudrin; Nikolai F Myasoedov; Natalia G Levitskaya","publishingOrg":"Neuropeptides","publicationYear":2021,"doi":"10.1016/j.npep.2020.102114","pubmedId":"33418449","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.npep.2020.102114","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1016/j.npep.2020.102114","pmid":"33418449","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"4baa3019-37dc-51d0-b0d1-3982b9597563","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"The Influence of Selank on the Level of Cytokines Under the Conditions of \"Social\" Stress.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32621722/","evidenceTier":"observational","summary":"PubMed-indexed journal article; research support, non-u.s. gov't examining the influence of selank on the level of cytokines under the conditions of \"social\" stress. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Yasenyavskaya A Leonidovna; Samotrueva M Aleksandrovna; Tsibizova A Aleksandrovna; Bashkina O Aleksandrovna; Myasoedov N Fedorovich; Andreeva L Aleksandrovna","publishingOrg":"Current reviews in clinical and experimental pharmacology","publicationYear":2021,"doi":"10.2174/1574884715666200704152810","pubmedId":"32621722","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.2174/1574884715666200704152810","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.2174/1574884715666200704152810","pmid":"32621722","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"8e918b37-39f5-5cff-9631-90223ac2582a","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/34097675/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining [the peptide drug acth(4-7)pgp (semax) suppresses mrna transcripts encoding proinflammatory mediators induced by reversible ischemia of the rat brain]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"L V Dergunova; V G Dmitrieva; I B Filippenkov; V V Stavchansky; A E Denisova; V V Yuzhakov; L E Sevan'kaeva; L V Valieva; O Y Sudarkina; L V Gubsky; N F Myasoedov; S A Limborska","publishingOrg":"Molekuliarnaia biologiia","publicationYear":2021,"doi":"10.31857/S0026898421010043","pubmedId":"34097675","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.31857/s0026898421010043","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.31857/S0026898421010043","pmid":"34097675","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"462233a5-9701-50e6-a8b1-d2abd259e8d3","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Correction of Lipid Metabolism Disorders in Diabetes Mellitus with Peptide Drugs.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32246363/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining correction of lipid metabolism disorders in diabetes mellitus with peptide drugs. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"A A Elagina; Yu D Lyashev; A Yu Lyashev; T V Pronyaeva; A R Chahine","publishingOrg":"Bulletin of experimental biology and medicine","publicationYear":2020,"doi":"10.1007/s10517-020-04764-2","pubmedId":"32246363","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s10517-020-04764-2","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1007/s10517-020-04764-2","pmid":"32246363","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"8cf0b4ac-e317-5aaf-88b7-1a593fff1775","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Functional Connectomic Approach to Studying Selank and Semax Effects.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32342318/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining functional connectomic approach to studying selank and semax effects. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ya R Panikratova; I S Lebedeva; O Yu Sokolov; A D Rumshiskaya; D A Kupriyanov; N V Kost; N F Myasoedov","publishingOrg":"Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections","publicationYear":2020,"doi":"10.1134/S001249662001007X","pubmedId":"32342318","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1134/s001249662001007x","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1134/S001249662001007X","pmid":"32342318","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"9b164437-b43d-567b-81b9-c63b64cf3b91","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32580520/","evidenceTier":"animal","summary":"PubMed-indexed journal article; research support, non-u.s. gov't examining novel insights into the protective properties of acth(4-7)pgp (semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Olga Y Sudarkina; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova","publishingOrg":"Genes","publicationYear":2020,"doi":"10.1126/scitranslmed.aaf8732","pubmedId":"32580520","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1126/scitranslmed.aaf8732","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1126/scitranslmed.aaf8732","pmid":"32580520","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"8ad559c2-8c7c-51a9-a14a-32847f30103a","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Pharmacological Aspects of Neuro-Immune Interactions.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/28875850/","evidenceTier":"observational","summary":"PubMed-indexed journal article; research support, non-u.s. gov't; review examining pharmacological aspects of neuro-immune interactions. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Vadim V Tarasov; Nikita V Kudryashov; Vladimir N Chubarev; Tatiana S Kalinina; George E Barreto; Ghulam Md Ashraf; Gjumrakch Aliev","publishingOrg":"Current pharmaceutical design","publicationYear":2018,"doi":"10.2174/1381612823666170829135115","pubmedId":"28875850","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.2174/1381612823666170829135115","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't; Review"},"provenancePayload":{"doi":"10.2174/1381612823666170829135115","pmid":"28875850","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"c255e920-d18b-5c70-80bb-ee6b1147afa8","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/29798983/","evidenceTier":"phase_1_2","summary":"PubMed-indexed clinical trial; journal article examining [the efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"E I Gusev; M Yu Martynov; E V Kostenko; L V Petrova; S N Bobyreva","publishingOrg":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","publicationYear":2018,"doi":"10.17116/jnevro20181183261-68","pubmedId":"29798983","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.17116/jnevro20181183261-68","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"human_interventional","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Clinical Trial; Journal Article"},"provenancePayload":{"doi":"10.17116/jnevro20181183261-68","pmid":"29798983","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"7d5a6464-fc4a-57fc-8fee-0dad0f081199","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Influence of ACTG4-7-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/28577097/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining influence of actg4-7-pgp (semax) on morphofunctional state of hepatocytes in chronic emotional and painful stress. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"A V Ivanov; I I Bobyntsev; O M Shepeleva; A A Kryukov; L A Andreeva; N F Myasoedov","publishingOrg":"Bulletin of experimental biology and medicine","publicationYear":2017,"doi":"10.1007/s10517-017-3748-4","pubmedId":"28577097","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s10517-017-3748-4","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1007/s10517-017-3748-4","pmid":"28577097","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"18a81b90-9387-598d-8196-00d778d7e560","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/28255762/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining semax, an analog of acth(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ekaterina V Medvedeva; Veronika G Dmitrieva; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova","publishingOrg":"Molecular genetics and genomics : MGG","publicationYear":2017,"doi":"10.1007/s00438-017-1297-1","pubmedId":"28255762","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s00438-017-1297-1","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1007/s00438-017-1297-1","pmid":"28255762","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"af743379-242e-50a5-bc4f-fc1d727ff415","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[A comparative chemoreactome analysis of mexidol].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/28514338/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining [a comparative chemoreactome analysis of mexidol]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"I Yu Torshin; O A Gromova; I S Sardaryan; L E Fedotova","publishingOrg":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","publicationYear":2017,"doi":"10.17116/jnevro20171171275-84","pubmedId":"28514338","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.17116/jnevro20171171275-84","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.17116/jnevro20171171275-84","pmid":"28514338","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"8668ff53-ba67-5851-b094-8cc49629e8da","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[POSSIBLE ROLE OF TRANSTHYRETIN IN THE BIOLOGICAL MECHANISM OF THE REGULATORY PEPTIDE NEUROPROTECTION.].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/30383932/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining [possible role of transthyretin in the biological mechanism of the regulatory peptide neuroprotection.]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"T V Vyunova; E V Medvedeva; L A Andreeva; L V Dergunova; S A Limborska; N F Myasoedov","publishingOrg":"Molekuliarnaia genetika, mikrobiologiia i virusologiia","publicationYear":2016,"doi":null,"pubmedId":"30383932","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:30383932","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":null,"pmid":"30383932","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"98772dbd-af5f-5a4d-b02b-56664527e413","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Sigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/24877185/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining sigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Scott L Charland; Eric J Stanek","publishingOrg":"Pharmacotherapy","publicationYear":2014,"doi":"10.1002/phar.1368","pubmedId":"24877185","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1002/phar.1368","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1002/phar.1368","pmid":"24877185","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"43665890-5958-52cf-a44e-cffcbde78b23","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/24661604/","evidenceTier":"animal","summary":"PubMed-indexed journal article; research support, non-u.s. gov't examining the peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ekaterina V Medvedeva; Veronika G Dmitrieva; Oksana V Povarova; Svetlana A Limborska; Veronika I Skvortsova; Nikolay F Myasoedov; Lyudmila V Dergunova","publishingOrg":"BMC genomics","publicationYear":2014,"doi":"10.1161/01.STR.12.6.723","pubmedId":"24661604","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1161/01.str.12.6.723","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1161/01.STR.12.6.723","pmid":"24661604","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"7ead1d1d-c2ce-5e32-839c-6a9b908ee9a4","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/22772900/","evidenceTier":"animal","summary":"PubMed-indexed journal article; research support, non-u.s. gov't examining effect of semax and its c-terminal fragment pro-gly-pro on the expression of vegf family genes and their receptors in experimental focal ischemia of the rat brain. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Ekaterina V Medvedeva; Veronika G Dmitrieva; Oksana V Povarova; Svetlana A Limborska; Veronika I Skvortsova; Nikolay F Myasoedov; Lyudmila V Dergunova","publishingOrg":"Journal of molecular neuroscience : MN","publicationYear":2013,"doi":"10.1007/s12031-012-9853-y","pubmedId":"22772900","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s12031-012-9853-y","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1007/s12031-012-9853-y","pmid":"22772900","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"57fd7f9a-a078-525e-a934-3ca78437995d","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[Nootropic and analgesic effects of Semax following different routes of administration].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/21268834/","evidenceTier":"observational","summary":"PubMed-indexed english abstract; journal article examining [nootropic and analgesic effects of semax following different routes of administration]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"D M Manchenko; N Iu Glazova; N G Levitskaia; L A Andreeva; A A Kamenskiĭ; N F Miasoedov","publishingOrg":"Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova","publicationYear":2010,"doi":null,"pubmedId":"21268834","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:21268834","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"English Abstract; Journal Article"},"provenancePayload":{"doi":null,"pmid":"21268834","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"c4841809-5424-5e83-98b1-e310970a3374","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[Evolution of the stress concept].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/19140465/","evidenceTier":"observational","summary":"PubMed-indexed english abstract; journal article; review examining [evolution of the stress concept]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"K V Sudakov","publishingOrg":"Vestnik Rossiiskoi akademii meditsinskikh nauk","publicationYear":2008,"doi":null,"pubmedId":"19140465","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:19140465","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"English Abstract; Journal Article; Review"},"provenancePayload":{"doi":null,"pmid":"19140465","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"77ec4e33-acf7-51cb-9423-5890a25296e6","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","title":"[Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/16634437/","evidenceTier":"observational","summary":"PubMed-indexed comparative study; journal article; review examining [comparison of anticoagulant effects of regulatory proline-containing oligopeptides. specificity of glyprolines, semax, and selank and potential of their practical application]. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"L A Liapina; V E Pastorova; T Iu Obergan; G E Samonina; I P Ashmarin; N F Miasoedov","publishingOrg":"Izvestiia Akademii nauk. Seriia biologicheskaia","publicationYear":2006,"doi":null,"pubmedId":"16634437","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:46.836Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:16634437","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:46.836Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Comparative Study; Journal Article; Review"},"provenancePayload":{"doi":null,"pmid":"16634437","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:46.836Z","updatedAt":"2026-09-09T19:33:05.147Z"}],"regulatory":[{"id":"9d481c81ae2d93647c1aba02f1b843ce","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","jurisdiction":"European Union","status":"not_approved","approvedIndication":null,"rationale":"No marketing authorization identified in the cited official portal; absence is machine-staged and requires accountable recheck.","sourceTitle":"EMA medicines portal","sourceUrl":"https://www.ema.europa.eu/en/medicines","dateChecked":"2026-09-09T11:45:21.643Z","reviewDueAt":"2027-03-08T11:45:21.643Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T11:45:21.643Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"3bfd4d7fbf222350b45433a5de31bce5","peptideId":"addc933f-2e6f-42f7-9686-2c1f6da5e728","jurisdiction":"United States","status":"not_approved","approvedIndication":null,"rationale":"No FDA marketing approval identified. FDA separately reports limited safety information and potential risks for compounded Semax.","sourceTitle":"FDA compounding safety-risk list","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","dateChecked":"2026-09-09T11:45:21.643Z","reviewDueAt":"2027-03-08T11:45:21.643Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T11:45:21.643Z","updatedAt":"2026-09-09T19:33:05.147Z"}],"claims":[],"correctionHistory":[],"boundaries":{"observationsAreEvidence":false,"completionIsPublicationApproval":false,"medicalAdvice":false}}